Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine gargles and nasal rinses in COVID-19
NCT04344236Phase 2Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Apr 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of povidone-iodine in coronavirus disease 2019 (COVID-19), sponsored by NYU Langone Health. Planned start Apr 2020; status: withdrawn.
02
Drugs
povidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04344236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344236.